8,976
Total Claims
$683K
Drug Cost
704
Beneficiaries
$970
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-91%
Opioid rate vs peers
0.2% vs 2.2% avg
-31%
Cost per patient vs peers
$970 vs $1,411 avg
+19%
Brand preference vs peers
12.7% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
18
Opioid Claims
$174
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
87% generic
Brand: 1,127 claims · $530K
Generic: 7,762 claims · $149K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 107 | $85K |
| Fluticasone/Umeclidin/Vilanter | 111 | $73K |
| Apixaban | 94 | $65K |
| Insulin Glargine,hum.Rec.Anlog | 34 | $23K |
| Semaglutide | 11 | $22K |
| Sitagliptin Phosphate | 15 | $14K |
| Semaglutide | 12 | $14K |
| Rivaroxaban | 18 | $14K |
| Insulin Lispro Protamin/Lispro | 13 | $13K |
| Dulaglutide | 12 | $12K |
| Atorvastatin Calcium | 653 | $11K |
| Rosuvastatin Calcium | 335 | $11K |
| Exenatide Microspheres | 14 | $11K |
| Mirabegron | 18 | $10K |
| Budesonide/Formoterol Fumarate | 26 | $10K |
Prescribing Profile
Patient Profile
75
Avg Age
53%
Female
1.26
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About